Submit request or call to make an appointment.
Medulloblastoma is one of the most common pediatric brain tumors, accounting for 15% to 20% of all brain tumors in children. Medulloblastoma usually occurs in children between ages 3 and 8, but could be seen in children or adults of any age.
The board-certified pediatric hematology/oncology specialists with Norton Children’s Cancer Institute, affiliated with the UofL School of Medicine, have the training and experience to treat children with medulloblastoma.
Medulloblastoma is a tumor in the cerebellum. The cerebellum is the part of the brain that controls coordination, balance and complex motor functions. The condition most often occurs in the central part of the cerebellum. In many cases, it is unknown why medulloblastoma develops. For some children, medulloblastoma is associated with inheritable conditions, such as Li-Fraumeni syndrome, Gorlin syndrome and Turcot syndrome.
Brain tumors such as medulloblastoma can cause a variety of symptoms in children based on age and location of the tumor. Symptoms can resemble other more common conditions or medical issues. Each child will experience symptoms differently, but common medulloblastoma symptoms can include:
The specialists with Norton Children’s Cancer Institute will work with you and your child to develop a treatment plan unique to your child’s condition. The treatment plan will be based on:
Children with medulloblastoma may need to be treated by specialists from across the Norton Children’s network, including neurosurgery, neuro-oncology, neurology, radiation oncology and more. Treatments can include: